UBS Group »

Calliditas Therap Adr Rep 2 Ord shares owned by UBS Group

Quarter-by-quarter ownership of Calliditas Therap Adr Rep 2 Ord (CALT) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Calliditas Therap Adr Rep 2 Ord

Tip: Access up to 7 years of quarterly data

All positions including Calliditas Therap Adr Rep 2 Ord held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calliditas Therap Adr Rep 2 Ord by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $25k 952 25.74
2023-09-30 $749 41 18.27
2023-06-30 $2.8k 177 15.84
2023-03-31 $7.3k 306 23.97
2022-12-31 $7.6k 449 17.00
2022-09-30 $4.0k 259 15.44
2022-06-30 $11k 636 17.30
2022-03-31 $29k 1.5k 19.46
2021-12-31 $36k 1.5k 24.71
2021-09-30 $4.0k 162 24.69
2021-06-30 $0 11 0.00
2021-03-31 $19k 691 27.50
2020-09-30 $20k 836 23.92